Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Ringkasan berita
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Ikuti berita terkini daripada penerbit yang dipercayai dengan ringkasan ringkas. Buka pautan sumber asal untuk butiran.